Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1 to 25 of 2555

TitleReference numberPublishedLast updated
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida (terminated appraisal)TA1154
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more lines of systemic treatmentTA1153
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesityTA1152
Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancerTA1150
Inebilizumab for treating immunoglobulin G4-related disease (terminated appraisal)TA1151
Digital technologies to support self-management of asthma: early-use assessmentHTG778
Acne vulgaris: managementNG198
Digital technologies for managing non-specific low back pain: early value assessmentHTG712
Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myelomaTA1149
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and overTA1147
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA1148
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitorsTA1146
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinomaTA1145
Ovarian cancer: recognition and initial managementCG122
Suspected cancer: recognition and referralNG12
Menopause: identification and managementNG23
Ovarian cancerQS18
Transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistulaHTG777
Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal)TA1144
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessmentHTG776
Fertility problems: assessment and treatmentNG257
Fertility problemsQS73
Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopauseTA1143
Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophilsTA1142
Fetal monitoring in labourNG229

Results per page

  1. 10
  2. 25
  3. 50
  4. All